Parmax Pharma Ltd.

Financial

	Parmax Pharma	Beryl Drugs	Adline Chem Lab
Operational Metrics
Financials
5 yr Average ROE	-1624.87 %	2.54 %	51.73 %
5yr average Equity Multiplier	46.04	2.23	0.93
5yr Average Asset Turnover Ratio	0.95	1.08	0.25
5yr Avg Net Profit Margin	-9.48 %	0.66 %	15.43 %
Price to Book	0.0	1.26	0.0
P/E	0.0	50.58	0.0
5yr Avg Cash Conversion Cycle	-161.05 Days	-619.24 Days	0.0
Inventory Days	73.65 Days	36.1 Days	40.82 Days
Days Receivable	40.27 Days	98.89 Days	0.0
Days Payable	328.05 Days	969.29 Days	61.52 Days
5yr Average Interest Coverage Ratio	1.16	1.68	10.45
5yr Avg ROCE	-9.94 %	5.73 %	-27.86 %
5yr Avg Operating Profit Margin	3.93 %	7.19 %	-8.78 %
5 yr average Debt to Equity	17.42	0.64	-0.21
5yr CAGR Net Profit	n/a	72.78 %	-37.71 %
5yr Average Return on Assets	-6.43 %	1.31 %	-1534.04 %
Shareholdings
Promoter Holding	30.8 %	26.38 %	25.85 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	1.46 %	-4.32 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0